Alerts

Consumers and health professionals are advised that Stryker Australia, in consultation with the TGA, has issued a hazard alert to surgeons regarding its Oasys Midline Occipital Plate.

Consumers and health professionals are advised that Medtronic Australasia, in consultation with the TGA, has initiated a recall for product correction for its Medtronic SynchroMed II and SynchroMed EL implantable infusion pumps.

The TGA warns that Plexus Slim Accelerator Capsules and the 3-Day Trial Pack are unsafe and illegal in Australia because they contain a banned substance that can cause serious health problems.

Health professionals and consumers are advised that Medtronic Australasia is issuing a hazard alert for its Consulta Cardiac Resynchronization Therapy Pacemaker (CRT-P).

Health professionals and consumers are advised that GE Healthcare, in consultation with the TGA, has initiated a recall for product correction for a number of its nuclear medicine imaging systems.

B. Braun Australia is withdrawing the cementless version of the Columbus Knee System from the Australian Register of Therapeutic Goods (ARTG). They have also issued a related hazard alert to surgeons.

Synthes Australia, in consultation with the TGA, is recalling unused stock of its 3.7 mm and 5.0 mm Dynamic Locking Screws.

Consumers and health professionals are advised that Medtronic, in consultation with the TGA, has initiated a recall for product correction for its Medtronic Paradigm insulin infusion sets.

Yong Gang tablets contain undeclared prescription substances and pose serious health risks. Stop using them and return any remaining tablets to your pharmacy. Consult your doctor if you have concerns.

Johnson & Johnson Medical has initiated a recall of all unused stock and issued a hazard alert to implanting surgeons for two Codman Certas Programmable Valve products.

The TGA has issued updated safety advice for health professionals regarding dabigatran (Pradaxa), highlighting the increased risk of bleeding and the importance of careful patient selection and monitoring, especially in older adults and those with kidney impairment.

TGA has issued updated safety advice for consumers taking Pradaxa (dabigatran), highlighting risks such as bleeding and the importance of proper storage and patient monitoring.

Health professionals and consumers are advised that Roche Diagnostics Australia, after consultation with the TGA, has initiated a recall for product correction for its CoaguChek XS, CoaguChek XS Plus and CoaguChek XS Pro INR monitors.